EMEIS SA (ORP.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ORP • FR001400NLM4

12.465 EUR

+0.15 (+1.24%)

Last: Jul 2, 2024, 05:28 PM

Fundamental Rating

ORP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. While ORP is still in line with the averages on profitability rating, there are concerns on its financial health. ORP is not priced too expensively while it is growing strongly. Keep and eye on this one!

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ORP was profitable.
ORP had a positive operating cash flow in the past year.
Of the past 5 years ORP 4 years were profitable.
Each year in the past 5 years ORP had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 9.74%, ORP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 71.82%, ORP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	9.74%
ROE	71.82%
ROIC	N/A

ROA(3y)-5.89%

ROA(5y)-3.02%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ORP's Profit Margin of 26.07% is amongst the best of the industry. ORP outperforms 100.00% of its industry peers.
ORP's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for ORP so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	26.07%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y85.55%

PM growth 5Y32.24%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ORP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ORP has been reduced compared to 1 year ago.
ORP has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.39, we must say that ORP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.39, ORP is doing worse than 85.71% of the companies in the same industry.
A Debt/Equity ratio of 4.30 is on the high side and indicates that ORP has dependencies on debt financing.
ORP's Debt to Equity ratio of 4.30 is on the low side compared to the rest of the industry. ORP is outperformed by 85.71% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	4.3
Debt/FCF	N/A
Altman-Z	0.39

ROIC/WACCN/A

WACC5.23%

2.3 Liquidity

A Current Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
ORP has a Current ratio of 0.60. This is amonst the worse of the industry: ORP underperforms 85.71% of its industry peers.
A Quick Ratio of 0.60 indicates that ORP may have some problems paying its short term obligations.
With a Quick ratio value of 0.60, ORP is not doing good in the industry: 71.43% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	0.6
Quick Ratio	0.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 360.39% over the past year.
The Earnings Per Share has been growing by 116.08% on average over the past years. This is a very strong growth
The Revenue has grown by 11.04% in the past year. This is quite good.
ORP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.73% yearly.

EPS 1Y (TTM)360.39%

EPS 3Y301.6%

EPS 5Y116.08%

EPS Q2Q%278.1%

Revenue 1Y (TTM)11.04%

Revenue growth 3Y9.84%

Revenue growth 5Y8.73%

Sales Q2Q%11.4%

3.2 Future

ORP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.14% yearly.
ORP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.11% yearly.

EPS Next Y99.7%

EPS Next 2Y41.51%

EPS Next 3Y26.14%

EPS Next 5YN/A

Revenue Next Year6.41%

Revenue Next 2Y9.12%

Revenue Next 3Y8.11%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ORP is valuated cheaply with a Price/Earnings ratio of 1.20.
Based on the Price/Earnings ratio, ORP is valued cheaper than 100.00% of the companies in the same industry.
ORP is valuated cheaply when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
ORP is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	1.2
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ORP's earnings are expected to grow with 26.14% in the coming years.